Access to Care and Adherence Tuberculosis (TB) Survey

Overview

Prompt access to care and treatment adherence are the hearth of tuberculosis control. This is a multicentre observational prospective study aimed at studying the factors associated with delayed access to care and low adherence to anti-tuberculosis treatment. Hetero- and self-administered questionnaires will be used at enrollment to assess clinical presentation and time and modalities of the diagnosis. Treatment adherence will be assessed during the follow-up with self administered questionnaires.

Full Title of Study: “Survey Nazionale Sui Determinanti Del Ritardato Accesso Alle Cure e Della Mancata Aderenza al Trattamento Antitubercolare (National Survey on the Determinats of Delayed Access to Care and Non-adherence to Tuberculosis Treatment)”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: September 2012

Clinical Trial Outcome Measures

Primary Measures

  • Time to TB diagnosis
    • Time Frame: Study enrollment

Participating in This Clinical Trial

Inclusion Criteria

  • >= 18 yrs of age – recent new TB diagnosis – Tuberculosis treatment prescribed – Ability to sign the informed consent

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Azienda Ospedaliera San Gerardo di Monza
  • Provider of Information About this Clinical Study
    • Principal Investigator: Giuseppe Lapadula, MD, PhD – Azienda Ospedaliera San Gerardo di Monza
  • Overall Official(s)
    • Giuseppe Lapadula, MD, PhD, Principal Investigator, Clinic of Infectious Disease, AO San Gerardo, Monza, Italy

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.